Molecular Brain Research · 1998 · 14 citations · 20 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyMolecular PharmacologySignal TransductionLigand BindingLigand-receptor InteractionsReceptor BindingReceptor PharmacologyReceptor PhysiologyReceptor-ligand InteractionsLigand Binding AffinityMembrane Receptor PharmacologyMembrane Receptor StructureReceptor-ligand BindingReceptor-ligand Structural Biology
Key amino terminal residues in type 1 (AT1) angiotensin II (AngII) receptors are not conserved within type 2 (AT2) receptors. We therefore characterized amino terminal mutants that are transiently expressed in COS-3 membranes. AT2 amino terminal deletion drastically reduced affinity for AngII, suggesting its importance for this subtype. AT1-AT2 amino terminal exchanges retained wild type AngII affinities (Kd ranging from 3-5 nM), indicating compensation despite substantial sequence dissimilarities. Finally, binding of AT2 selective ligands (CGP42112A and PD123319) was not dependent on the amino terminus.
20
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension
Robert M. Horton, Henry D. Hunt, Steffan N. Ho et al. · Gene · 1989 · 3.1K citations
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
T J Murphy, R. Wayne Alexander, Kathy K. Griendling et al. · Nature · 1991 · 1.3K citations